Peptide record

TPDB11078

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
29 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11078
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 29-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFMDTAKNVAKNVAVTLIDKLRCKVTGGC
Physicochemical Analysis
C131H226N38O39S3
EQHPSWY
KV
3053.65
9.71
5
2
12
+3
5.02
0.228
90.69
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
4.09
7
Residue Composition
number
3
A
1
R
2
N
2
D
2
C
0
E
0
Q
3
G
0
H
1
I
2
L
4
K
1
M
1
F
0
P
0
S
3
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 3 R: 1 N: 2 D: 2 C: 2 E: 0 Q: 0 G: 3 H: 0 I: 1 L: 2 K: 4 M: 1 F: 1 P: 0 S: 0 T: 3 W: 0 Y: 0 V: 4
Chemical Descriptors
29
C131H226N38O39S3
3053.65
9.71
+3
5.02
0.228
Evidence Records 41 records
Evidence 1 Activity

Activity

MIC
Antibacterial
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 2 Activity

Activity

MIC
Antibacterial
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 3 Activity

Activity

MIC
Antibacterial
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 4 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

dbAMP DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

dbAMP DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 6 Activity

Activity

MIC
Antibacterial
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

dbAMP DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 7 Activity

Activity

MIC
Antibacterial
50 µM

Target

B. dysenteriae

Source & Reference

dbAMP DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 8 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 9 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 10 Activity

Activity

MIC
Antifungal
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 11 Activity

Activity

MIC
Antifungal
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 12 Activity

Activity

MIC
Antifungal
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 13 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 14 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 15 Activity

Activity

MIC
Antifungal
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 16 Activity

Activity

MIC
Antifungal
50 µM

Target

B. dysenteriae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 17 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 18 Activity

Activity

MIC
Antifungal
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 19 Activity

Activity

MIC
Antiparasitic
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 20 Activity

Activity

MIC
Antiparasitic
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 21 Activity

Activity

MIC
Antiparasitic
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 22 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 23 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 24 Activity

Activity

MIC
Antiparasitic
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 25 Activity

Activity

MIC
Antiparasitic
50 µM

Target

B. dysenteriae

Source & Reference

DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 26 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 27 Activity

Activity

MIC
Antiparasitic
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 28 Activity

Activity

MIC
Antiviral
20 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MI
Evidence 29 Activity

Activity

MIC
Antiviral
20 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

DRAMP

Other

Active against Gram+ S. aureus ATCC25923 (MIC 20 uM), E. faecalis ATCC29212 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25
Evidence 30 Activity

Activity

MIC
Antiviral
13 µM

Target

Escherichia coli ATCC25922

Source & Reference

DRAMP

Other

12 (MIC 20 uM), S.aureus IS 10# (MIC >200 ug/ml), S.aureus IS 37# (MIC >200 ug/ml), Gram- E. coli ATCC25922 (MIC 13 uM), E.coli (IS 37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >
Evidence 31 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

E.cloacae ATCC13047

Source & Reference

DRAMP

Other

37#) (MIC >200 ug/ml), E.coli IS 117# (MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aerugin
Evidence 32 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

K.pneumonia ATCC700603

Source & Reference

DRAMP

Other

(MIC >200 ug/ml), E.coli IS 218# (MIC >200 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MI
Evidence 33 Activity

Activity

MIC
Antiviral
20 µM

Target

B. pyocyaneus CMCCB1010

Source & Reference

DRAMP

Other

00 ug/ml), E.cloacae ATCC13047 (MIC >200 ug/ml), K.pneumonia ATCC700603 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC
Evidence 34 Activity

Activity

MIC
Antiviral
50 µM

Target

B. dysenteriae

Source & Reference

DRAMP

Other

3 (MIC >200 ug/ml), B. pyocyaneus CMCCB1010 (MIC 20 uM), P. aeruginosa ATCC27853 (33 uM), B. dysenteriae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATC
Evidence 35 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

ae (MIC 50 uM), P. aeruginosa IS 350# (MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Not
Evidence 36 Activity

Activity

MIC
Antiviral
>200 µg/mL

Target

C.albicans ATCC2002

Source & Reference

DRAMP

Other

(MIC 50 uM), K. pneumonia IS 59# (MIC 50 uM), fungi C.albicans ATCC2002 (MIC >200 ug/ml), C.albicans ATCC2002 (MIC >200 ug/ml), and C. albicans ATCC2002 (MIC MIC >200 ug/ml). Note that the activity of the synthetic v
Evidence 37 Activity

Activity

IC50
Hemolysis
135 µM
[Ref:21816202] IC50=135 µM against human and rabbit erythrocytes

Target

human

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Biochimie. 2012 Feb 94(2):328-334.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 38 Activity

Activity

50% Hemolysis
Toxicity
135 µM
Hemolytic Cytotoxic
50% Hemolysis | 135 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. | Biochimie | 2012
Evidence 39 Activity

Activity

50% Hemolysis
Toxicity
135 µM
Hemolytic Cytotoxic
50% Hemolysis | 135 | µM | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis. | Biochimie | 2012
Evidence 40 Activity

Activity

IC50
Toxicity
135 µM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref:21816202] IC50=135 µM against human and rabbit erythrocytes | Cytotoxicity: [Ref.21816202] Cytotoxicity: the K562 (IC50=58µM) and HT29 mammalian cell lines(IC50=57µM).

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochimie. 2012 Feb 94(2):328-334.
Evidence 41 Hemolysis

Activity

135 µM
IC50
[Ref:21816202] IC50=135 µM against human and rabbit erythrocytes
Hemolysis

Target

human

Source & Reference

APD_complete HemoPI PD_Hemolysis
Biochimie. 2012 Feb 94(2):328-334.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.